Creative Biolabs Unveils One-stop BsAb Development Services at Immuno-Oncology Summit

October 19 01:00 2022
Creative Biolabs has introduced the upgraded bispecific antibody (BsAb) development service portfolio at the 10th Annual Immuno-Oncology Summit, covering BsAb design, purification, engineering, and manufacturing.

New York, USA – October 18, 2022 – Immuno-oncology (IO), emerging as a novel approach to taking advantage of the body’s immune system to fight cancer, has been a game changer in cancer treatment research. With abundant antibody development experience over the past years, Creative Biolabs is dedicated to offering a full range of bispecific antibody (BsAb) development services, and recently has introduced the upgraded service portfolio at the 10th Annual Immuno-Oncology Summit on October 12, 2022.

Creative Biolabs participates in this great event in the field of IO research as the corporate sponsor and exhibitor. The on-site scientists enjoyed the brilliant speeches, especially the discussions on the topic of Bispecific Antibodies for Cancer Immunotherapy, and met many old and new friends at booth #9. During the exhibition, the most asked service is the newly-updated BsAb development services, which cover:

* Bispecific Antibody Design

Creative Biolabs offers customized BsAb designs and experimental workflows either for fundamental research or clinical trials. The scientist team has accumulated rich experience in BsAb design based on targets (epitopes, ligands, receptors, immune cells, etc.), applications (oncology, hematology, immunology, ophthalmology, radio-immunotherapy, etc.), and MOA (immune cell recruitment, receptor signaling interference, forced protein associations, and payload delivery).

* Bispecific Antibody Purification

Creative Biolabs provides a series of purification strategies to meet unique requirements, including protein A/G/L chromatography, tag-based purification, etc.

* Bispecific Antibody Engineering

The scientist team also provides BsAb engineering services to adjust their properties including size, valency, flexibility, half-life, biodistribution, etc., or other specific requirements, covering bispecific IgGs, bispecific fusion proteins, appended IgGs, BsAb conjugates, BsAb Fragments, etc.

* Bispecific Antibody Manufacturing

Three strategies are available at Creative Biolabs to develop BsAbs and achieve large-scale generation for customers as follows: Genetic Engineering, Hybrid-hybridoma Technology, and Chemical Conjugation.

Through updating the technology platform and the workflow on BsAb development and manufacturing, Creative Biolabs aims to help clients improve lab’s efficiency, get more data, and decrease the time to discovery.

On December 4-8, 2022, Creative Biolabs will participate in the Antibody Engineering & Therapeutics (US) in San Diego, CA, and the scientist team look forward to meeting more friends at booth #418. Find more information about BsAb development services & products and upcoming events at

About Creative Biolabs

With more than a decade of exploration and expansion, Creative Biolabs has been dedicated to offering services on antibody discovery, engineering, production, and analysis. Especially, the bispecific antibody (BsAb) team has gathered a collective of experienced scientists committed to providing high-quality services to customers all over the world, covering BsAb design, purification, engineering, manufacturing, and BsAb analysis service. Besides, a variety of standard or customized BsAb products are also available for different research applications.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States